Management of Abnormal Uterine Bleeding in Hypertensive Women

Safety Profile and Contraindications

The American College of Obstetricians and Gynecologists recommends progestin-only contraceptives as the first-line hormonal option for women with hypertension, as they are safe and appropriate for this population 1, 2
Combined hormonal contraceptives are absolutely contraindicated in hypertensive women due to a 6-9 fold increased risk of myocardial infarction and 8-15 fold increased risk of stroke 2
Progestin-only methods show no increased cardiovascular risk in hypertensive women 2
The American College of Obstetricians and Gynecologists also notes that progestin-only therapy is safe for women with hypertension, with no significant interactions between oral progesterone and common antihypertensive medications like amlodipine or telmisartan 1, 2

The American Heart Association, as published in Circulation, suggests that levonorgestrel intrauterine device (20 μg/day) is a highly effective option for reducing menstrual blood loss, with a 71-95% reduction, and is safe for use in hypertensive women 3
Cyclic oral progesterone (400 mg daily for 10-14 days per month) can reduce bleeding by 87%, although it may cause irregular spotting, according to guidelines from the American College of Obstetricians and Gynecologists 3

Blood pressure must be checked every 6 months while on any hormonal therapy, even progestin-only methods, as recommended by the American College of Obstetricians and Gynecologists 1, 2
The American Academy of Family Physicians recommends that chronic management can be continued for 3-6 months, then reassessed 4
The American Heart Association, as published in Circulation, notes that if using levonorgestrel IUD, it is effective for up to 5 years 3

Before prescribing, ensure the patient does not have undiagnosed abnormal genital bleeding, known or suspected breast cancer, active or history of venous thromboembolism, known liver dysfunction, pregnancy, or peanut allergy, as recommended by the American College of Radiology and the American Academy of Family Physicians 3, 4, 5

Before prescribing progestin therapy, pregnancy must be excluded through a pregnancy test, according to the American Academy of Family Physicians 6, 7

The American Heart Association recommends considering a Levonorgestrel IUD (20 μg/day) as a medical option for reducing menstrual blood loss by 71-95%, with efficacy comparable to endometrial ablation, particularly suitable for hypertensive women due to minimal systemic progesterone absorption 8, 9

The American College of Cardiology guidelines suggest that patients with cardiovascular disease history should avoid NSAIDs or tranexamic acid due to thrombotic risks 8, 9

The American Academy of Family Physicians recommends ensuring adequate diagnostic workup per PALM-COEIN classification to rule out structural causes before attributing bleeding to ovulatory dysfunction 6, 7